InsiderTrades.com logo
Successful Options Trading Begins With…
From Tradewins   |   Ad
Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!
Download the guide here and see the difference!

BCDA Insider Trading

Insider Ownership Percentage: 23.90%
Insider Buying (Last 12 Months): $1,014,246.84
Insider Selling (Last 12 Months): $0.00

BioCardia Insider Trading History Chart

This chart shows the insider buying and selling history at BioCardia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioCardia Share Price & Price History

Current Price: $0.41
Price Change: ▲ Price Increase of +0.03 (7.98%)
As of 09/22/2023 01:00 AM ET

This chart shows the closing price history over time for BCDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
No Matter The Market, Options Trading Could Earn You More
From Tradewins   |   Ad
There’s no way to predict Wall Street’s future, but by using options trading, you have the opportunity to take advantage of any trend. Expert Wendy Kirkland explains how in her latest free guide.
Download it for free here!

BioCardia Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2023Peter AltmanCEOBuy6,200$1.60$9,920.00469,239View SEC Filing Icon  
1/11/2023Peter AltmanCEOBuy100$1.87$187.00353,715View SEC Filing Icon  
12/16/2022Phillip Md Et Al FrostMajor ShareholderBuy595,238$1.68$999,999.842,025,827View SEC Filing Icon  
10/10/2022David McclungCFOBuy2,000$2.07$4,140.0078,518View SEC Filing Icon  
9/23/2022Peter AltmanCEOBuy1,400$1.87$2,618.00328,447View SEC Filing Icon  
9/21/2022Peter AltmanCEOBuy2,750$1.92$5,280.00323,947View SEC Filing Icon  
6/10/2022Peter AltmanCEOBuy4,500$1.46$6,570.00321,197View SEC Filing Icon  
5/13/2022Peter AltmanCEOBuy2,698$1.38$3,723.24348,143View SEC Filing Icon  
5/11/2022Peter AltmanCEOBuy1,000$1.30$1,300.00334,143View SEC Filing Icon  
4/28/2022Peter AltmanCEOBuy2,300$1.59$3,657.00330,443View SEC Filing Icon  
4/18/2022Peter AltmanCEOBuy13,500$1.39$18,765.00328,143View SEC Filing Icon  
11/18/2021Peter AltmanCEOBuy5,000$2.20$11,000.00View SEC Filing Icon  
8/17/2021Peter AltmanCEOBuy3,500$2.94$10,290.00232,909View SEC Filing Icon  
12/1/2020Peter AltmanCEOBuy1,000$2.49$2,490.00203,200View SEC Filing Icon  
11/27/2020Peter AltmanCEOBuy3,200$2.37$7,584.00203,200View SEC Filing Icon  
11/12/2020Peter AltmanCEOBuy2,000$2.07$4,140.00205,900View SEC Filing Icon  
11/10/2020Peter AltmanCEOBuy2,500$1.98$4,950.00203,900View SEC Filing Icon  
11/2/2020Eric DuckersInsiderSell8,435$2.01$16,954.3512,088View SEC Filing Icon  
See Full Table
Free Stock Analysis Report: Buy Sell Hold Predictions on Any Stock
From Vector Vest   |   Ad
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Analyze Any Stock Free

SEC Filings (Institutional Ownership Changes) for BioCardia (NASDAQ:BCDA)

16.46% of BioCardia stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BCDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioCardia Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/11/2023BlackRock Inc.33,013$88K0.0%N/A0.161%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC145,155$0.39M0.0%+50.3%0.710%Search for SEC Filing on Google Icon
8/4/2023CM Management LLC343,000$0.92M0.9%+4.3%1.677%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.30,751$82K0.0%+93.5%0.150%Search for SEC Filing on Google Icon
5/16/2023Family Management Corp77,500$0.15M0.0%-45.5%0.384%Search for SEC Filing on Google Icon
5/15/2023AIGH Capital Management LLC509,151$0.99M0.4%-14.5%2.523%Search for SEC Filing on Google Icon
4/12/2023Vontobel Holding Ltd.15,895$31K0.0%N/A0.079%Search for SEC Filing on Google Icon
2/16/2023AIGH Capital Management LLC595,237$1.24M0.4%N/A2.969%Search for SEC Filing on Google Icon
2/10/2023Advisor Group Holdings Inc.47,843$100K0.0%-9.5%0.239%Search for SEC Filing on Google Icon
11/15/2022Family Management Corp142,186$0.28M0.1%N/A0.797%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC28,312$42K0.0%N/A0.162%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC13,700$28K0.0%N/A0.081%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.650,523$1.35M0.0%+57.9%3.856%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP27,407$57K0.0%N/A0.162%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC49,978$0.10M0.0%+18.1%0.296%Search for SEC Filing on Google Icon
1/31/2022Commonwealth Equity Services LLC42,307$82K0.0%+156.5%0.251%Search for SEC Filing on Google Icon
11/5/2021Advisor Group Holdings Inc.39,257$0.12M0.0%-8.4%0.233%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC16,492$51K0.0%N/A0.098%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC33,264$0.13M0.0%N/A0.197%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP21,680$86K0.0%-45.7%0.129%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP21,680$86K0.0%-45.7%0.129%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC102,230$0.41M0.0%-66.5%0.609%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC76,825$0.30M0.0%+23.6%0.457%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.411,969$1.64M0.0%+67.8%2.453%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC329,000$1.31M0.9%+5.1%1.959%Search for SEC Filing on Google Icon
8/6/2021Magnus Financial Group LLC15,000$60K0.0%N/A0.089%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC46,945$0.20M0.0%N/A0.280%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC305,200$1.33M0.0%N/A1.817%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC62,168$0.27M0.0%+175.6%0.370%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC313,100$1.36M1.0%+36.1%1.864%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp16,294$56K0.0%N/A0.131%Search for SEC Filing on Google Icon
2/5/2021CM Management LLC230,000$0.80M0.7%N/A1.851%Search for SEC Filing on Google Icon
8/17/2020Jane Street Group LLC14,688$35K0.0%N/A0.214%Search for SEC Filing on Google Icon
8/14/2020Captrust Financial Advisors659,179$1.62M0.0%N/A9.626%Search for SEC Filing on Google Icon
8/14/2020Advisor Group Holdings Inc.85,002$0.20M0.0%-7.7%1.241%Search for SEC Filing on Google Icon
5/18/2020Advisor Group Holdings Inc.92,083$0.31M0.0%N/A1.349%Search for SEC Filing on Google Icon
11/27/2019Millennium Management LLC41,978$0.14M0.0%N/A0.615%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioCardia logo
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Read More on BioCardia

Today's Range

Now: $0.41
Low: $0.38
High: $0.41

50 Day Range

MA: $0.91
Low: $0.37
High: $2.48

52 Week Range

Now: $0.41
Low: $0.36
High: $2.92

Volume

280,780 shs

Average Volume

162,661 shs

Market Capitalization

$8.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of BioCardia?

BioCardia's top insider investors include:
  1. Phillip Md Et Al Frost (Major Shareholder)
  2. Peter Altman (CEO)
  3. David Mcclung (CFO)
Learn More about top insider investors at BioCardia.

Who are the major institutional investors of BioCardia?

BioCardia's top institutional shareholders include:
  1. CM Management LLC — 1.68%
  2. Geode Capital Management LLC — 0.71%
  3. BlackRock Inc. — 0.16%
  4. Vontobel Holding Ltd. — 0.15%
  5. Citadel Advisors LLC — 0.00%
  6. Simplex Trading LLC — 0.00%
Learn More about top institutional investors of BioCardia stock.

Which institutional investors are selling BioCardia stock?

During the previous quarter, BCDA stock was sold by these institutional investors:
  1. Citadel Advisors LLC

Which institutional investors are buying BioCardia stock?

During the last quarter, BCDA stock was purchased by institutional investors including:
  1. Geode Capital Management LLC
  2. BlackRock Inc.
  3. Vontobel Holding Ltd.
  4. CM Management LLC
  5. Simplex Trading LLC
During the previous year, these company insiders have bought BioCardia stock:
  1. Phillip Md Et Al Frost (Major Shareholder)
  2. Peter Altman (CEO)
  3. David Mcclung (CFO)
Learn More investors buying BioCardia stock.
He's Giving Away His Ultimate Dividend Package FOR FREE!
From The Oxford Club   |   Ad
Marc Lichtenfeld, Author of Get Rich with Dividends, is giving away his Ultimate Dividend Package, Including Details on His #1 Dividend Stock... the Safest 8% Dividend in the World... the Top Three "Extreme Dividend" Stocks... and Much, Much More. For Free.
>>>